Macrocliniside A

Details

Top
Internal ID d310f04f-025f-4170-b2c1-f3cb09cb0673
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene lactones > Sesquiterpene lactones > Guaianolides and derivatives
IUPAC Name (3aS,5R,6aR,8S,9aR,9bS)-5-hydroxy-3,6,9-trimethylidene-8-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one
SMILES (Canonical) C=C1C2CC(C(=C)C2C3C(CC1O)C(=C)C(=O)O3)OC4C(C(C(C(O4)CO)O)O)O
SMILES (Isomeric) C=C1[C@@H]2C[C@@H](C(=C)[C@@H]2[C@@H]3[C@@H](C[C@H]1O)C(=C)C(=O)O3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O
InChI InChI=1S/C21H28O9/c1-7-10-5-13(28-21-18(26)17(25)16(24)14(6-22)29-21)9(3)15(10)19-11(4-12(7)23)8(2)20(27)30-19/h10-19,21-26H,1-6H2/t10-,11-,12+,13-,14+,15-,16+,17-,18+,19-,21+/m0/s1
InChI Key ARJUJAMZTUUZNZ-NJQUUYHGSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C21H28O9
Molecular Weight 424.40 g/mol
Exact Mass 424.17333247 g/mol
Topological Polar Surface Area (TPSA) 146.00 Ų
XlogP -1.40
Atomic LogP (AlogP) -1.22
H-Bond Acceptor 9
H-Bond Donor 5
Rotatable Bonds 3

Synonyms

Top
CHEMBL3622760
94474-61-0

2D Structure

Top
2D Structure of Macrocliniside A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6652 66.52%
Caco-2 - 0.8239 82.39%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.8143 81.43%
Subcellular localzation Mitochondria 0.6210 62.10%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8356 83.56%
OATP1B3 inhibitior + 0.9527 95.27%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.7652 76.52%
P-glycoprotein inhibitior - 0.7842 78.42%
P-glycoprotein substrate - 0.8128 81.28%
CYP3A4 substrate + 0.6080 60.80%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8596 85.96%
CYP3A4 inhibition - 0.8911 89.11%
CYP2C9 inhibition - 0.9202 92.02%
CYP2C19 inhibition - 0.8559 85.59%
CYP2D6 inhibition - 0.8966 89.66%
CYP1A2 inhibition - 0.8830 88.30%
CYP2C8 inhibition - 0.7243 72.43%
CYP inhibitory promiscuity - 0.9173 91.73%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.7650 76.50%
Eye corrosion - 0.9847 98.47%
Eye irritation - 0.8979 89.79%
Skin irritation - 0.7751 77.51%
Skin corrosion - 0.9479 94.79%
Ames mutagenesis - 0.6054 60.54%
Human Ether-a-go-go-Related Gene inhibition - 0.4593 45.93%
Micronuclear - 0.7800 78.00%
Hepatotoxicity - 0.6250 62.50%
skin sensitisation - 0.8491 84.91%
Respiratory toxicity + 0.6444 64.44%
Reproductive toxicity + 0.6667 66.67%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity + 0.6604 66.04%
Acute Oral Toxicity (c) III 0.4004 40.04%
Estrogen receptor binding + 0.6464 64.64%
Androgen receptor binding + 0.5884 58.84%
Thyroid receptor binding + 0.5732 57.32%
Glucocorticoid receptor binding - 0.4632 46.32%
Aromatase binding + 0.6683 66.83%
PPAR gamma + 0.5297 52.97%
Honey bee toxicity - 0.5930 59.30%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5900 59.00%
Fish aquatic toxicity + 0.7151 71.51%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.63% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.74% 97.09%
CHEMBL218 P21554 Cannabinoid CB1 receptor 89.45% 96.61%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.43% 94.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 84.32% 97.36%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.54% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.40% 95.56%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 81.90% 89.34%
CHEMBL2581 P07339 Cathepsin D 80.23% 98.95%

Cross-Links

Top
PubChem 10455028
NPASS NPC80144
LOTUS LTS0266397
wikiData Q104402655